Darzalex (daratumumab) - J&J
lenalidomide - Generic mfg.
Nplate (romiplostim) - Amgen
carfilzomib - Generic mfg.
dexamethasone - Generic mfg.
Talvey (talquetamab-tgvs) - J&J
Tecvayli (teclistamab-cqyv) - Genmab, J&J
Melflufen (melphalan flufenamide) - Oncopeptides
pomalidomide - Generic mfg.
Empliciti (elotuzumab) - AbbVie, BMS
Elrexfio (elranatamab-bcmm) - Pfizer
Xpovio (selinexor) - Karyopharm
https://ashpublications.org/blood/article/146/Supplement%201/7918/550027/Comprehensive-cost-analysis-of-4th-line-therapies
 
Ulrike Sager 1; Stefan Norin 2; Bastian Hatesuer 1
 
Dec 5, 2025
 
Next